New England Research & Management Inc. purchased a new stake in M.D.C. Holdings, Inc. (NYSE:MDC) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 34,430 shares of the construction company’s stock, valued at approximately $1,098,000. New England Research & Management Inc. owned 0.06% of M.D.C. at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of the company. Amalgamated Bank acquired a new stake in M.D.C. during the second quarter worth approximately $202,000. Capital Fund Management S.A. bought a new position in M.D.C. in the second quarter worth approximately $223,000. Sawgrass Asset Management LLC bought a new position in M.D.C. in the third quarter worth approximately $262,000. Parametrica Management Ltd bought a new position in M.D.C. in the third quarter worth approximately $285,000. Finally, Campbell & CO Investment Adviser LLC bought a new position in M.D.C. in the third quarter worth approximately $306,000. 74.15% of the stock is owned by institutional investors.
MDC has been the topic of several recent research reports. ValuEngine lowered M.D.C. from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 2nd. Citigroup dropped their target price on M.D.C. from $37.00 to $34.00 and set a “neutral” rating on the stock in a report on Friday, November 3rd. KeyCorp restated a “hold” rating on shares of M.D.C. in a report on Tuesday, September 26th. Zacks Investment Research upgraded M.D.C. from a “sell” rating to a “hold” rating in a report on Wednesday, October 4th. Finally, UBS Group started coverage on M.D.C. in a report on Wednesday, October 25th. They issued a “sell” rating and a $34.00 target price on the stock. Four investment analysts have rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $30.33.
Shares of M.D.C. Holdings, Inc. (NYSE MDC) traded down $0.22 on Tuesday, hitting $34.12. The company had a trading volume of 365,400 shares, compared to its average volume of 546,700. The company has a quick ratio of 2.60, a current ratio of 9.45 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $1,914.08, a P/E ratio of 12.24, a price-to-earnings-growth ratio of 0.88 and a beta of 1.36. M.D.C. Holdings, Inc. has a one year low of $25.87 and a one year high of $37.45.
M.D.C. (NYSE:MDC) last issued its quarterly earnings results on Thursday, November 2nd. The construction company reported $1.16 EPS for the quarter, beating the Zacks’ consensus estimate of $0.61 by $0.55. M.D.C. had a return on equity of 11.66% and a net margin of 6.09%. The company had revenue of $586.30 million during the quarter, compared to the consensus estimate of $595.05 million. During the same period last year, the business posted $0.54 earnings per share. M.D.C.’s revenue was up 1.4% on a year-over-year basis. sell-side analysts anticipate that M.D.C. Holdings, Inc. will post 2.69 EPS for the current year.
M.DC Holdings, Inc is engaged in two primary operations, including homebuilding and financial services. The Company’s segments include West, including segments located in Arizona, California, Nevada and Washington; Mountain, including segments located in Colorado and Utah; East, including segments located in Virginia, Florida and Maryland, which includes Pennsylvania and New Jersey; mortgage operations, including HomeAmerican Mortgage Corporation, and Other, which includes Allegiant Insurance Company, Inc, StarAmerican Insurance Ltd., American Home Insurance Agency, Inc and American Home Title and Escrow Company.
Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.